What is the recommended intravenous (IV) dose of aminophylline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aminophylline IV Dosing

For acute severe asthma in adults, administer a loading dose of 5-6 mg/kg aminophylline IV over 20-30 minutes (omit if patient already on theophylline), followed by a continuous infusion of 0.5 mg/kg/hr, with the goal of achieving a therapeutic serum theophylline concentration of 10-20 mcg/mL. 1, 2

Loading Dose Administration

Standard Loading Dose (Theophylline-Naive Patients)

  • Administer 5-6 mg/kg aminophylline IV over 20-30 minutes for patients who have not received theophylline in the previous 24 hours 1, 2
  • This loading dose produces an average post-distribution serum theophylline concentration of 10 mcg/mL (range 6-16 mcg/mL) 2
  • The 20-30 minute infusion time is critical to avoid toxicity including arrhythmias, hypotension, and seizures 3
  • Calculate dose based on ideal body weight, not total body weight, as theophylline distributes poorly into body fat 2

Patients Already on Theophylline

  • Do NOT give a loading dose without first obtaining a serum theophylline level if the patient has received any theophylline in the previous 24 hours 2
  • If a loading dose is necessary after measuring the serum level, calculate as: Loading Dose = (Desired concentration - Measured concentration) × 0.5 L/kg 2
  • Use a conservative target concentration of 10 mcg/mL to account for variability in volume of distribution 2

Maintenance Infusion Rates

Adults (Non-Smoking)

  • Start continuous infusion at 0.5 mg/kg/hr aminophylline (equivalent to 0.4 mg/kg/hr theophylline) immediately after the loading dose 2
  • This produces an average steady-state concentration of 10 mcg/mL (range 7-26 mcg/mL) 2

Pediatric Patients (Age 1-9 Years)

  • Administer loading dose of 5-6 mg/kg over 20 minutes, followed by continuous infusion of 1.0 mg/kg/hr aminophylline 1, 2
  • Children have higher theophylline clearance than adults, requiring higher maintenance doses 2
  • Research shows that 72% of pediatric patients had subtherapeutic levels within 5.5 hours of standard loading, with 78% requiring additional bolus doses, suggesting close monitoring is essential 4

High-Risk Populations Requiring Dose Reduction

  • In patients with cor pulmonale, cardiac decompensation, liver dysfunction, or those taking drugs that reduce theophylline clearance (e.g., cimetidine), do not exceed 21 mg/hr aminophylline unless serum concentrations can be monitored at 24-hour intervals 2
  • Theophylline clearance is decreased by 50% or more in patients with hepatic insufficiency or congestive heart failure 2
  • Elderly patients (>60 years) have 30% decreased clearance compared to young adults 2

Specific Clinical Indications

Second or Third-Degree AV Block with Acute Inferior MI

  • Administer 250 mg aminophylline as a single IV bolus 1, 3

Post-Heart Transplant or Spinal Cord Injury with Bradycardia

  • Administer 6 mg/kg aminophylline in 100-200 mL IV fluid over 20-30 minutes 1, 3

Acute Severe Asthma (Alternative Dosing from British Guidelines)

  • For small patients: 750 mg/24 hours continuous infusion 1
  • For large patients: 1500 mg/24 hours continuous infusion 1
  • Monitor blood concentrations if continued for over 24 hours 1

Monitoring Requirements

Timing of Serum Level Checks

  • Obtain first serum theophylline level 30 minutes after loading dose to assess need for additional loading and guide continuing therapy 2
  • Obtain second level one expected half-life after starting continuous infusion (approximately 4 hours in children age 1-9,8 hours in non-smoking adults) 2
  • If level is declining, administer additional loading dose and/or increase infusion rate 2
  • If level is rising above target, decrease infusion rate before concentration exceeds 20 mcg/mL 2
  • Obtain additional samples at 12-24 hours, then at 24-hour intervals for ongoing adjustments 2

Target Therapeutic Range

  • Maintain serum theophylline concentration between 10-20 mcg/mL 3, 2
  • Concentrations >20 mcg/mL are considered toxic 5
  • In high-risk patients, steady-state may require 5 days to achieve 2

Critical Safety Considerations

Administration Precautions

  • Always administer loading dose over 20-30 minutes, never as rapid IV push 1, 3, 2
  • Continuous cardiac monitoring is essential during infusion 3
  • Use ideal body weight for dose calculations in obese patients 2

Common Pitfalls to Avoid

  • Never assume a patient has not taken theophylline based on history alone - always obtain a serum level if there is any uncertainty 2
  • Research demonstrates that half-loading doses (3 mg/kg) in patients reporting recent theophylline use resulted in 23.2% developing toxic levels, indicating the unreliability of patient history 5
  • Nonlinearity of elimination may begin at concentrations <10 mcg/mL in some patients, so make dose adjustments in small increments 2
  • Patients with very high initial clearance rates have the greatest likelihood of experiencing large changes in serum concentration with dose changes 2

Drug Incompatibilities

  • Do not mix aminophylline with epinephrine HCl, isoproterenol HCl, or norepinephrine bitartrate due to compatibility concerns 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Aminophylline Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adequacy of recommended aminophylline loading doses in children.

American journal of hospital pharmacy, 1994

Research

Aminophylline loading in asthmatic patients: a protocol trial.

Annals of emergency medicine, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.